Cargando…

Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India

PURPOSE: Very few studies conducted in India have analyzed insurance policies and clinical trial agreement (CTA) submitted to ethics committee (EC). This study was conducted to review and find out deficiencies in it. MATERIALS AND METHODS: This was a retrospective observational study. All the protoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalikar, Mrunalini V., Dakhale, Ganesh N., Sinha, Vishakha V., Giradkar, Akhil B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345254/
https://www.ncbi.nlm.nih.gov/pubmed/35928639
http://dx.doi.org/10.4103/picr.PICR_124_20
_version_ 1784761378433662976
author Kalikar, Mrunalini V.
Dakhale, Ganesh N.
Sinha, Vishakha V.
Giradkar, Akhil B.
author_facet Kalikar, Mrunalini V.
Dakhale, Ganesh N.
Sinha, Vishakha V.
Giradkar, Akhil B.
author_sort Kalikar, Mrunalini V.
collection PubMed
description PURPOSE: Very few studies conducted in India have analyzed insurance policies and clinical trial agreement (CTA) submitted to ethics committee (EC). This study was conducted to review and find out deficiencies in it. MATERIALS AND METHODS: This was a retrospective observational study. All the protocols for regulatory clinical trials and academic research sponsored by the Indian Council of Medical Research or other funding agency were included. Insurance documents and CTA submitted with the study protocols were analyzed. RESULTS: A total of seventy CTA and insurance policies were analyzed. CTA mentioned that parties involved in 60 (86%) forms, scope of the agreement in 15 (21%) forms, responsibilities of the party in 68 (97%) forms, and payment details in 58 (83%) forms. Nearly 88.5% of the insurance policies mentioned whether the policy covers the participants for injury due to all clauses and 91% of the policies mentioned the validity period of insurance. CONCLUSION: It was found that both the documents contained almost all the required elements. This was probably because this institutional EC insisted on and thoroughly reviewed the documents to ensure that adequate compensation of research-related injuries has been provided for and this fact is informed to the trial subject. As very few studies are available in the literature, we could not compare majority of the findings of this study with others.
format Online
Article
Text
id pubmed-9345254
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-93452542022-08-03 Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India Kalikar, Mrunalini V. Dakhale, Ganesh N. Sinha, Vishakha V. Giradkar, Akhil B. Perspect Clin Res Original Article PURPOSE: Very few studies conducted in India have analyzed insurance policies and clinical trial agreement (CTA) submitted to ethics committee (EC). This study was conducted to review and find out deficiencies in it. MATERIALS AND METHODS: This was a retrospective observational study. All the protocols for regulatory clinical trials and academic research sponsored by the Indian Council of Medical Research or other funding agency were included. Insurance documents and CTA submitted with the study protocols were analyzed. RESULTS: A total of seventy CTA and insurance policies were analyzed. CTA mentioned that parties involved in 60 (86%) forms, scope of the agreement in 15 (21%) forms, responsibilities of the party in 68 (97%) forms, and payment details in 58 (83%) forms. Nearly 88.5% of the insurance policies mentioned whether the policy covers the participants for injury due to all clauses and 91% of the policies mentioned the validity period of insurance. CONCLUSION: It was found that both the documents contained almost all the required elements. This was probably because this institutional EC insisted on and thoroughly reviewed the documents to ensure that adequate compensation of research-related injuries has been provided for and this fact is informed to the trial subject. As very few studies are available in the literature, we could not compare majority of the findings of this study with others. Wolters Kluwer - Medknow 2022 2021-03-26 /pmc/articles/PMC9345254/ /pubmed/35928639 http://dx.doi.org/10.4103/picr.PICR_124_20 Text en Copyright: © 2021 Perspectives in Clinical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kalikar, Mrunalini V.
Dakhale, Ganesh N.
Sinha, Vishakha V.
Giradkar, Akhil B.
Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India
title Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India
title_full Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India
title_fullStr Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India
title_full_unstemmed Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India
title_short Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India
title_sort analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345254/
https://www.ncbi.nlm.nih.gov/pubmed/35928639
http://dx.doi.org/10.4103/picr.PICR_124_20
work_keys_str_mv AT kalikarmrunaliniv analysisofclinicaltrialagreementandinsurancepolicysubmittedtotheethicscommitteeofatertiarycareteachinginstituteincentralindia
AT dakhaleganeshn analysisofclinicaltrialagreementandinsurancepolicysubmittedtotheethicscommitteeofatertiarycareteachinginstituteincentralindia
AT sinhavishakhav analysisofclinicaltrialagreementandinsurancepolicysubmittedtotheethicscommitteeofatertiarycareteachinginstituteincentralindia
AT giradkarakhilb analysisofclinicaltrialagreementandinsurancepolicysubmittedtotheethicscommitteeofatertiarycareteachinginstituteincentralindia